GGrantIndex
← Leaderboards

Yan Yuan

University Of Pennsylvania

$11,534,388
Attributed
$11,534,388
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $851.7K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,534,388 · 8

By mechanism

R01$7,603,211 · 3
P01$3,264,220 · 3
R21$432,432 · 1
R29$234,525 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Human Herpesvirus 8

Research focus

Human Herpesvirus 8CellsVirusViralLife Cycle StagesLytic ReplicationLyticHerpesviridaeVirionEventLaboratoriesProteinsMalignant NeoplasmsInvestigationMediatingRecombinantsGenomeRegulationDna BiosynthesisHerpesviridae InfectionsMutagenesisParticleKaposi SarcomaAcquired Immunodeficiency Syndrome

Grant awards (39)

Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia$455,512
P01 · FY2025 · CA · contact PI
Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia$455,512
P01 · FY2024 · CA · contact PI
Roles of KSHV Tegument Proteins in Virion Assembly$413,012
R01 · FY2020 · DE · contact PI
Roles of KSHV Tegument Proteins in Virion Assembly$413,791
R01 · FY2019 · DE · contact PI
Roles of KSHV Tegument Proteins in Virion Assembly$429,843
R01 · FY2018 · DE · contact PI
KSHV Abortive Replication Following De Novo Infection$309,018
P01 · FY2017 · CA · contact PI
Recombinant Virus and Vector Core$155,393
P01 · FY2017 · CA · contact PI
KSHV Abortive Replication Following De Novo Infection$343,557
P01 · FY2016 · CA · contact PI
Recombinant Virus and Vector Core$172,022
P01 · FY2016 · CA · contact PI
KSHV Abortive Replication Following De Novo Infection$121,360
P01 · FY2015 · CA · contact PI
Recombinant Virus and Vector Core$60,766
P01 · FY2015 · CA · contact PI
KSHV Abortive Replication Following De Novo Infection$338,496
P01 · FY2014 · CA · contact PI
Recombinant Virus and Vector Core$233,353
P01 · FY2014 · CA · contact PI
KSHV-encoded Small Peptites$200,000
R21 · FY2014 · AI · contact PI
KSHV Abortive Replication Following De Novo Infection$349,226
P01 · FY2013 · CA · contact PI
Recombinant Virus and Vector Core$270,005
P01 · FY2013 · CA · contact PI
KSHV-encoded Small Peptites$232,432
R21 · FY2013 · AI · contact PI
KSHV-Ori-Lyt-Dependent DNA Replication$385,914
R01 · FY2012 · AI · contact PI
KSHV-Ori-Lyt-Dependent DNA Replication$385,914
R01 · FY2011 · AI · contact PI
KSHV-Ori-Lyt-Dependent DNA Replication$389,813
R01 · FY2010 · AI · contact PI
KSHV-Ori-Lyt-Dependent DNA Replication$425,243
R01 · FY2009 · AI · contact PI
Immediate-Early Genes of KSHV$285,611
R01 · FY2009 · CA · contact PI
KSHV-Ori-Lyt-Dependent DNA Replication$393,750
R01 · FY2008 · AI · contact PI
Immediate-Early Genes of KSHV$285,611
R01 · FY2008 · CA · contact PI
Immediate-Early Genes of KSHV$285,611
R01 · FY2007 · CA · contact PI
Role ofK8 bZip Protein in KSHV Lytic DNA Replication$309,551
R01 · FY2006 · AI · contact PI
Immediate-Early Genes of KSHV$293,284
R01 · FY2006 · CA · contact PI
Role ofK8 bZip Protein in KSHV Lytic DNA Replication$317,000
R01 · FY2005 · AI
Immediate-Early Genes of KSHV$300,263
R01 · FY2005 · CA
Role ofK8 bZip Protein in KSHV Lytic DNA Replication$317,000
R01 · FY2004 · AI
EARLY GENES OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS$285,300
R01 · FY2004 · CA
Role ofK8 bZip Protein in KSHV Lytic DNA Replication$317,000
R01 · FY2003 · AI
EARLY GENES OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS$285,300
R01 · FY2003 · CA
EARLY GENES OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS$285,300
R01 · FY2002 · CA
Role of K8 bZip Protein in KSHV Lytic DNA Replication$183,500
R01 · FY2002 · AI
EARLY GENES OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS$285,300
R01 · FY2001 · CA
EXTERNAL GUIDE SEQUENCE (EGS) AND AIDS THERAPY$119,250
R29 · FY2001 · GM
EARLY GENES OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS$330,300
R01 · FY2000 · CA
EXTERNAL GUIDE SEQUENCE (EGS) AND AIDS THERAPY$115,275
R29 · FY2000 · GM